The Release of the Bromodomain Ligand N,N-Dimethylacetamide Adds Bioactivity to a Resorbable Guided Bone Regeneration Membrane in a Rabbit Calvarial Defect Model

Epigenetic drugs as new therapy for tumor necrosis factor-α-compromised bone healing

(2019) Tse-Hsiang Chen et al.   BONE

Repurposing N,N-Dimethylacetamide (DMA), a Pharmaceutical Excipient, as a Prototype Novel Anti-inflammatory Agent for the Prevention and/or Treatment of Preterm Birth

(2018) Samir Gorasiya et al.   CURRENT PHARMACEUTICAL DESIGN

Guided bone regeneration: materials and biological mechanisms revisited

(2017) Ibrahim Elgali et al.   EUROPEAN JOURNAL OF ORAL SCIENCES

Engineering Membranes for Bone Regeneration

(2017) Sofia G. Caridade et al.   TISSUE ENGINEERING PART A

Bone Regeneration Using N-Methyl-2-pyrrolidone as an Enhancer for Recombinant Human Bone Morphogenetic Protein-2 in a Rabbit Sinus Augmentation Model

(2017) Hyun-Chang Lim et al.   Biomed Research International

N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment

(2017) Chafik Ghayor et al.   Scientific Reports

N,N-Dimethylacetamide Significantly Attenuates LPS- and TNFα-Induced Proinflammatory Responses Via Inhibition of the Nuclear Factor Kappa B Pathway

(2016) Ryan Pekson et al.   MOLECULAR MEDICINE

The epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosis

(2015) Bebeka Gjoksi et al.   BONE

N-methyl pyrrolidone (NMP) inhibits lipopolysaccharide-induced inflammation by suppressing NF-κB signaling

(2015) Chafik Ghayor et al.   INFLAMMATION RESEARCH

Comparative study of NMP-preloaded and dip-loaded membranes for guided bone regeneration of rabbit cranial defects

(2014) Lindsay S. Karfeld-Sulzer et al.   Journal of Tissue Engineering and Regenerative Medicine

Horizontal bone augmentation by means of guided bone regeneration

(2014) Goran I. Benic et al.   PERIODONTOLOGY 2000

N,N-Dimethylacetamide Regulates the Proinflammatory Response Associated with Endotoxin and Prevents Preterm Birth

(2013) Sruthi Sundaram et al.   AMERICAN JOURNAL OF PATHOLOGY

A randomized controlled clinical multicenter trial comparing the clinical and histological performance of a new, modified polylactide-co-glycolide acid membrane to an expanded polytetrafluorethylene membrane in guided bone regeneration procedures

(2013) David Schneider et al.   CLINICAL ORAL IMPLANTS RESEARCH

Inhibition of Osteoclast Differentiation and Bone Resorption byN-Methylpyrrolidone

(2011) Chafik Ghayor et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

(2011) Wendy B. London et al.   JOURNAL OF CLINICAL ONCOLOGY

Guided bone regeneration with a synthetic biodegradable membrane: a comparative study in dogs

(2010) Ronald E. Jung et al.   CLINICAL ORAL IMPLANTS RESEARCH

Guided Bone Regeneration: biological principle and therapeutic applications

(2010) M. Retzepi et al.   CLINICAL ORAL IMPLANTS RESEARCH

Comparison of two resorbable membrane systems in bone regeneration after removal of wisdom teeth: a randomized-controlled clinical pilot study

(2009) Roger A. Zwahlen et al.   CLINICAL ORAL IMPLANTS RESEARCH

N-Methyl Pyrrolidone as a Potent Bone Morphogenetic Protein Enhancer for Bone Tissue Regeneration

(2009) Blanca San Miguel et al.   TISSUE ENGINEERING PART A

Brd4 Coactivates Transcriptional Activation of NF- B via Specific Binding to Acetylated RelA

(2008) B. Huang et al.   MOLECULAR AND CELLULAR BIOLOGY